Eqitx to raise $1.8 million

By Melissa Trudinger
Tuesday, 07 December, 2004

Melbourne-based biotech managed investment group EQiTX (ASX: EQX) will ask shareholders to approve a AUD$1.8 million capital raising to provide working capital for its two projects ZingoTX and VacTX.

The placement, involving the issue of six million new shares at $0.30 plus two million free attaching options with an exercise price of $0.20, is to be underwritten by Cunningham Securities.

$780m Sydney Biomedical Accelerator gains its founding Executive Director

Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...

Portable point-of-care test detects four common STIs in under an hour

Australian researchers have developed a portable point-of-care test that detects four common...

AusBiotech and Proto Axiom partner on investor-focused life sciences programs

AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...

Content from other channels on our network

Ahpra launches the National Scheme Strategy 2031

The Agency establishes National Clinical Governance Committee for Digital Health

'No evidence' of medicinal cannabis effectiveness treating anxiety, depression or PTSD

COVID-19 training fail lands residential aged care provider $150K fine

AdPha partners with Therapeutic Guidelines to deliver obesity clinical guidance

New fund drives waste sector innovation

Epson on CDP 'A List'

APCO and SPSA partner on soft plastics stewardship

Partnership creates national manufacturing roadmap

$2.1bn battery recycling sector critical to Australia's sovereign capability

ARENA awards $13m for industrial decarbonisation

NVIDIA working with global robotics companies on physical AI

Physical AI set to transform industrial operations: report

Queensland announces $200m for sustainable energy in the North West

Industry Growth Program supports 13 new commercialisation projects